Clinical trial · Observational
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
ETUDE NEOMEL: TRAITEMENT NEOADJUVANT PAR IMMUNOTHERAPIE DU MELANOME METASTATIQUE OPERABLE EN VIE REELLE (GCC)
NCT06586593CI-TRIAL-00080883NEOMELrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate efficacy and tolerance of real life neoadjuvant immunotherapy in advanced yet operable melanoma. The complete histological response will be assessed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma Metastatic | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Operable metastatic melanoma
- description
- Operable metastatic melanoma
Primary outcomes (1)
- measure
- Complete histological response
- timeFrame
- Day 1
- description
- Histological response rate on histological analysis of the resected specimen
Secondary outcomes (7)
- measure
- Objectival response rate
- timeFrame
- Day 1
- description
- Objectival response rate on imaging
- measure
- Event-free survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with operable metastatic melanoma (stage III or IV of American Joint Committee on Cancer \[AJCC\] Stages CLassification) treated with neoadjuvant immunotherapy (anti-PD1 or anti-PD1 + anti-CTLA-4), even if surgery cancelled due to disease progression or complete response or patient\'s refusal to be operated. * Efficacy of the neoadjuvant immunotherapy histologically of radiologically assessed Exclusion Criteria: * Uveal melanoma
References
Publications (0)
Data not yet available
No reference posted for this study.